CYP3A4 and breast cancer: Conversely, miR148a increases levels of CYP3A4 and CYP2C19 and is downregulated in a number of cancers, including most of the lower gastrointestinal (GI) tumors, along with head & neck cancers, breast cancer, lung cancer and melanoma [80].